BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28757391)

  • 41. Reducing CXCR4-mediated nociceptor hyperexcitability reverses painful diabetic neuropathy.
    Jayaraj ND; Bhattacharyya BJ; Belmadani AA; Ren D; Rathwell CA; Hackelberg S; Hopkins BE; Gupta HR; Miller RJ; Menichella DM
    J Clin Invest; 2018 Jun; 128(6):2205-2225. PubMed ID: 29533926
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Astrocytic NDRG2 is involved in glucocorticoid-mediated diabetic mechanical allodynia.
    Zuo ZF; Liao YH; Ding T; Dong YL; Qu J; Wang J; Wei YY; Lu YC; Liu XZ; Li YQ
    Diabetes Res Clin Pract; 2015 Apr; 108(1):128-36. PubMed ID: 25656762
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dexmedetomidine attenuates P2X4 and NLRP3 expression in the spine of rats with diabetic neuropathic pain.
    Kang L; Yayi H; Fang Z; Bo Z; Zhongyuan X
    Acta Cir Bras; 2019; 34(11):e201901105. PubMed ID: 31859818
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The induction of the transcription factor Nrf2 enhances the antinociceptive effects of delta-opioid receptors in diabetic mice.
    McDonnell C; Leánez S; Pol O
    PLoS One; 2017; 12(7):e0180998. PubMed ID: 28700700
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dexmedetomidine attenuates renal fibrosis via α2-adrenergic receptor-dependent inhibition of cellular senescence after renal ischemia/reperfusion.
    Li Q; Chen C; Chen X; Han M; Li J
    Life Sci; 2018 Aug; 207():1-8. PubMed ID: 29729264
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gabapentin reduces allodynia and hyperalgesia in painful diabetic neuropathy rats by decreasing expression level of Nav1.7 and p-ERK1/2 in DRG neurons.
    Zhang JL; Yang JP; Zhang JR; Li RQ; Wang J; Jan JJ; Zhuang Q
    Brain Res; 2013 Feb; 1493():13-8. PubMed ID: 23183040
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dosing time-dependent changes in the analgesic effect of pregabalin on diabetic neuropathy in mice.
    Akamine T; Koyanagi S; Kusunose N; Hashimoto H; Taniguchi M; Matsunaga N; Ohdo S
    J Pharmacol Exp Ther; 2015 Jul; 354(1):65-72. PubMed ID: 25962390
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Spinal-supraspinal and intrinsic μ-opioid receptor agonist-norepinephrine reuptake inhibitor (MOR-NRI) synergy of tapentadol in diabetic heat hyperalgesia in mice.
    Christoph T; Schröder W; Tallarida RJ; De Vry J; Tzschentke TM
    J Pharmacol Exp Ther; 2013 Dec; 347(3):794-801. PubMed ID: 24051022
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antinociceptive effects of fisetin against diabetic neuropathic pain in mice: Engagement of antioxidant mechanisms and spinal GABAA receptors.
    Zhao X; Li XL; Liu X; Wang C; Zhou DS; Ma Q; Zhou WH; Hu ZY
    Pharmacol Res; 2015 Dec; 102():286-97. PubMed ID: 26520392
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dexmedetomidine decreases hyperalgesia in neuropathic pain by increasing acetylcholine in the spinal cord.
    Kimura M; Saito S; Obata H
    Neurosci Lett; 2012 Oct; 529(1):70-4. PubMed ID: 22917606
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diabetes-induced mechanical hyperalgesia involves spinal mitogen-activated protein kinase activation in neurons and microglia via N-methyl-D-aspartate-dependent mechanisms.
    Daulhac L; Mallet C; Courteix C; Etienne M; Duroux E; Privat AM; Eschalier A; Fialip J
    Mol Pharmacol; 2006 Oct; 70(4):1246-54. PubMed ID: 16868181
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Defective autophagy contributes to bupivacaine-induced aggravation of painful diabetic neuropathy in db/db mice.
    Fan K; Liao Q; Yuan P; Xu R; Liu Z
    Neuropharmacology; 2024 Mar; 245():109814. PubMed ID: 38104768
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of Adenylyl Cyclase in the Spinal Cord Alleviates Painful Diabetic Neuropathy in Zucker Diabetic Fatty Rats.
    Feng H; Lu G; Li Q; Liu Z
    Can J Diabetes; 2017 Apr; 41(2):177-183. PubMed ID: 27889175
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence for suppression of spinal glial activation by dexmedetomidine in a rat model of monoarthritis.
    Xu B; Zhang WS; Yang JL; Lû N; Deng XM; Xu H; Zhang YQ
    Clin Exp Pharmacol Physiol; 2010 Oct; 37(10):e158-66. PubMed ID: 20626414
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effects of galanin on neuropathic pain in streptozotocin-induced diabetic rats.
    Xu X; Liu Z; Liu H; Yang X; Li Z
    Eur J Pharmacol; 2012 Apr; 680(1-3):28-33. PubMed ID: 22306246
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phosphorylation of spinal N-methyl-d-aspartate receptor NR1 subunits by extracellular signal-regulated kinase in dorsal horn neurons and microglia contributes to diabetes-induced painful neuropathy.
    Daulhac L; Maffre V; Mallet C; Etienne M; Privat AM; Kowalski-Chauvel A; Seva C; Fialip J; Eschalier A
    Eur J Pain; 2011 Feb; 15(2):169.e1-169.e12. PubMed ID: 20594879
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antihypernociceptive and neuroprotective effects of Combretin A and Combretin B on streptozotocin-induced diabetic neuropathy in mice.
    Mbiantcha M; Khalid R; Dawe A; Mehreen A; Atsamo DA; Ateufack G; Hamza D; Nana WY; Bomba FTD; Naeem RU; Izhar A
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Jun; 392(6):697-713. PubMed ID: 30759263
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain.
    Toth CC; Jedrzejewski NM; Ellis CL; Frey WH
    Mol Pain; 2010 Mar; 6():16. PubMed ID: 20236533
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Specific functioning of Cav3.2 T-type calcium and TRPV1 channels under different types of STZ-diabetic neuropathy.
    Khomula EV; Viatchenko-Karpinski VY; Borisyuk AL; Duzhyy DE; Belan PV; Voitenko NV
    Biochim Biophys Acta; 2013 May; 1832(5):636-49. PubMed ID: 23376589
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Systemic and spinal administration of etanercept, a tumor necrosis factor alpha inhibitor, blocks tactile allodynia in diabetic mice.
    Dogrul A; Gul H; Yesilyurt O; Ulas UH; Yildiz O
    Acta Diabetol; 2011 Jun; 48(2):135-42. PubMed ID: 21104419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.